By Newsbreak Producer Matthew Veeran - A collaborative study has been launched in England to investigate potential genetic links to acute pancreatitis in individuals using weight loss drugs like Mounjaro, Ozempic and Wegovy. This follows hundreds of reported cases, including ten fatalities. The initiative encourages patients aged 18 and over - who have experienced severe reactions and hospitalisation from these medications - to report their experiences and provide saliva samples for genetic analysis. The ultimate goal here is to identify individuals at higher genetic risk of adverse reactions, paving the way for a healthcare system focused on preventing such serious side effects. Matthew found out more in this week's Medical Monitor...

#PODCAST Verulam Water Crisis Committee relay frustrations as residents feel impact of continued supply disruptions #sabcnews
06:02

#PODCAST Economists warn that private transport services will bear brunt of possible "exorbitant" April fuel hike #sabcnews
03:48

#PODCAST Boil water advisory issued for Amanzimtoti and surrounding areas amid serious water quality concerns #sabcnews
03:11